(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Sales | 3,796 | 3,629 | 3,905 | |
| Gross Profit | 116 | 80 | 43 | |
| Net income | 107 | (24) | 601 |
| separate financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Sales | 2,205 | 2,292 | 2,240 | |
| Gross Profit | 66 | 90 | 60 | |
| Net income | 118 | 48 | 596 |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Asset | ||||
| Ⅰ. Current asset | 2,855 | 2,823 | 2,802 | |
| Ⅱ. Non-current asset | 10,237 | 10,181 | 10,292 | |
| Total Assets | 13,092 | 13,004 | 13,094 | |
| Liability | ||||
| Ⅰ. Current Liabilites | 5,979 | 2,110 | 1,713 | |
| Ⅱ. Non-Current Liabilities | 1,473 | 5,376 | 5,844 | |
| Total Liabilities | 7,452 | 7,486 | 7,557 | |
| Stockholder's Equity | ||||
| Ⅰ. Capital Stock | 3,940 | 3,940 | 3,940 | |
| Ⅱ. Other payment Capital | (231) | (255) | (255) | |
| Ⅲ. Other Capital | (493) | (493) | (493) | |
| Ⅳ. Earned surplus | 2,424 | 2,327 | 2,344 | |
| Total Stockholders Equity | 5,640 | 5,519 | 5,536 | |
| separate financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Asset | ||||
| Ⅰ. Current asset | 2,104 | 2,238 | 2,164 | |
| Ⅱ. Non-current asset | 10,459 | 10,336 | 10,414 | |
| Total Assets | 12,563 | 12,574 | 12,578 | |
| Liability | ||||
| Ⅰ. Current Liabilites | 5,738 | 1,965 | 1,537 | |
| Ⅱ. Non-Current Liabilities | 1,417 | 5,335 | 5,820 | |
| Total Liabilities | 7,155 | 7,300 | 7,357 | |
| Stockholder's Equity | ||||
| Ⅰ. Capital Stock | 3,941 | 3,941 | 3,941 | |
| Ⅱ. Other payment Capital | (230) | (255) | (255) | |
| Ⅲ. Other Capital | (491) | (491) | (491) | |
| Ⅳ. Earned surplus | 2,188 | 2,079 | 2,026 | |
| Total Stockholders Equity | 5,408 | 5,274 | 5,221 | |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Ⅰ. Sales | 3,376 | 3,629 | 3,904 | |
| Ⅱ. Cost of sales | 2,571 | 2,453 | 2,799 | |
| Ⅲ. Gross Margin | 1,225 | 1,176 | 1,105 | |
| Ⅳ. Selling and Administrative Expenses | 1,109 | 1,096 | 1,062 | |
| Ⅴ. Operation Income | 116 | 80 | 43 | |
| Ⅵ. Other income | 121 | 104 | 59 | |
| Ⅶ. Other expenses | 60 | 170 | 120 | |
| Ⅷ. Finance income | 27 | 20 | 6 | |
| Ⅸ. Finance costs | 209 | 186 | 204 | |
| Ⅹ. Equity method income | 130 | 132 | 1,024 | |
| XV. Equity method Loss | - | 0 | 0 | |
| XVI. Income before income tax | 125 | (20) | 808 | |
| XVII. Income tax expenses | 18 | 4 | 207 | |
| XVIII. Continuously Operation Income | 107 | (24) | 601 | |
| XV. Discontinued Operation Income | - | - | - | |
| XVI. Net income | 107 | (24) | 601 |
| separate financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Ⅰ. Sales | 2,205 | 2,292 | 2,240 | |
| Ⅱ. Cost of sales | 1,249 | 1,308 | 1,344 | |
| Ⅲ. Gross Margin | 956 | 984 | 896 | |
| Ⅳ. Selling and Administrative Expenses | 890 | 894 | 836 | |
| Ⅴ. Operation Income | 66 | 90 | 60 | |
| Ⅵ. Other income | 114 | 95 | 54 | |
| Ⅶ. Other expenses | 93 | 150 | 103 | |
| Ⅷ. Finance income | 17 | 15 | 7 | |
| Ⅸ. Finance costs | 207 | 183 | 203 | |
| Ⅹ. Equity method income | 218 | 180 | 1,056 | |
| XV. Equity method Loss | 1 | 11 | 72 | |
| XVI. Income before income tax | 114 | 36 | 799 | |
| XVII. Income tax expenses | (4) | (12) | 203 | |
| XVIII. Continuously Operation Income | 118 | 48 | 596 | |
| XV. Discontinued Operation Income | - | - | - | |
| XVI. Net Income | 118 | 48 | 596 |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Ⅰ. Cash Flows from Operating Activities | 152 | (27) | 244 | |
| Ⅱ. Cash Flows from Investing Activities | 6 | (9) | 114 | |
| Ⅲ. Cash Flows from Financing Activities | (192) | (251) | (550) | |
| Ⅳ. Increase or Decrease in Cash and Cash Equivalents | (34) | (287) | (192) | |
| Ⅴ. Cash and Cash Equivalent at Beginning | 226 | 513 | 705 | |
| Ⅵ. Cash and Cash Equivalent at End | 192 | 226 | 513 | |
| separate financial statements |
Subject
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
| Ⅰ. Cash Flows from Operating Activities | 89 | (31) | 167 | |
| Ⅱ. Cash Flows from Investing Activities | (32) | 80 | 219 | |
| Ⅲ. Cash Flows from Financing Activities | (174) | (235) | (537) | |
| Ⅳ. Increase or Decrease in Cash and Cash Equivalents | (117) | (186) | (151) | |
| Ⅴ. Cash and Cash Equivalent at Beginning | 197 | 383 | 534 | |
| Ⅵ. Cash and Cash Equivalent at End | 80 | 197 | 383 |
